Clinical trial
Prevalence and Long Tem Follow up of ATTR Cardiac Amyloidosis in a Selected Population of Patients Operated on Carpal Tunnel Syndrome
NCT06458374 is registered in ClinicalTrials.gov with Helse Møre og Romsdal HF as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevalence and Long Tem Follow up of ATTR Cardiac Amyloidosis in a Selected Population of Patients Operated on Carpal Tunnel Syndrome
- Lead sponsor
- Helse Møre og Romsdal HF
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- September 1, 2024
- Completion date
- February 28, 2039
- Enrollment
- 180 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
attr amyloidosis wild type, attr gene mutation, cardiac amyloidosis, carpal tunnel syndrome